Core Alternative Capital’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-26
Closed -$2.14K – 297
2025
Q3
$2.14K Hold
26
– – ﹤0.01% 240
2025
Q2
$2.09K Sell
26
-100
-79% -$7.72K ﹤0.01% 231
2025
Q1
$10.1K Sell
126
-13
-9% -$1.08K ﹤0.01% 182
2024
Q4
$11.4K Buy
139
+100
+256% +$8.32K ﹤0.01% 203
2024
Q3
$3.22K Hold
39
– – ﹤0.01% 246
2024
Q2
$2.74K Hold
39
– – ﹤0.01% 247
2024
Q1
$2.89K Sell
39
-230
-86% -$16K ﹤0.01% 243
2023
Q4
$17.8K Sell
269
-54
-17% -$3.38K ﹤0.01% 233
2023
Q3
$20.3K Buy
323
+1
+0.3% +$62 ﹤0.01% 251
2023
Q2
$18.2K Buy
322
+43
+15% +$2.39K ﹤0.01% 238
2023
Q1
$16.2K Buy
279
+63
+29% +$4.25K ﹤0.01% 250
2022
Q4
$15.6K Hold
216
– – ﹤0.01% 238
2022
Q3
$13K Sell
216
-77
-26% -$4.92K ﹤0.01% 254
2022
Q2
$18K Buy
293
+123
+72% +$8.14K ﹤0.01% 230
2022
Q1
$12K Buy
170
+116
+215% +$7.84K ﹤0.01% 246
2021
Q4
$3K Buy
+54
New +$3.39K ﹤0.01% 249

Other funds holding MET

Core Alternative Capital's MET Position: Q4 2025 in Review

Core Alternative Capital sold out of MetLife (MET) in Q4 2025, closing a stake of 26 shares — an estimated $2.14K sold.

Core Alternative Capital first reported a position in MET in Q4 2021 and held it in 16 quarters. The position peaked at $20.3K in Q3 2023. 1,447 funds tracked by Wall St. Rank hold MET as of Q4 2025.

  • Core Alternative Capital reported no remaining MetLife position as of Q4 2025 after selling out during the quarter.
  • Core Alternative Capital sold 26 MetLife shares in Q4 2025, an estimated $2.14K.
  • Core Alternative Capital first reported a position in MetLife in Q4 2021 and held it in 16 quarters.
  • Core Alternative Capital's MetLife position peaked at $20.3K in Q3 2023.
  • 1,447 funds tracked by Wall St. Rank held MetLife as of Q4 2025.

Based on Core Alternative Capital's 13F filing for Q4 2025, filed 2 Feb 2026.